ConductScience.org, home

Gene522

ATP5PF: ATP synthase peripheral stalk subunit F6

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. ATP5PF: ATP synthase peripheral stalk subunit F6. Genes, record 522. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/522

FollowSave as evidence

Gene

Symbol
ATP5PF
HGNC
Name
ATP synthase peripheral stalk subunit F6
HGNC
NCBI Gene ID
522
NCBI Gene
HGNC ID
HGNC:847
HGNC
Ensembl
ENSG00000154723
NCBI Gene
Aliases
ATP5, ATP5A, ATP5J, ATPM, CF6, F6
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P18859ATP synthase peripheral stalk subunit F6, mitochondrial1089Ensembl, GeneID, HGNC

Source UniProt

Patents76

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1438120P18859Espacenet
JP 2026004568 A2026-01-1438121P18859Espacenet
JP 2026004568 A2026-01-1438122P18859Espacenet
JP 2026004568 A2026-01-1438123P18859Espacenet
JP 2026004568 A2026-01-1438124P18859Espacenet
EP 4650780 A22025-11-193240P18859Espacenet
JP 2025517970 A2025-06-123240P18859Espacenet
JP 2025062604 A2025-04-147089P18859Espacenet
JP 2025062604 A2025-04-147090P18859Espacenet
JP 2025062604 A2025-04-147091P18859Espacenet

See all 76 patents

NIH grants771

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleATP5PF papersNewest fiscal year
P30CA016672Cancer Center Support Grant52025
P30CA042014Cancer Center Support Grant32025
R35GM118141Mitochondrial Biogenesis in Health and Disease32025
P30CA006973Regional Oncology Research Center22025
P30CA014195Cancer Center Support Grant (CCSG)22025
P30CA016056Roswell Park Cancer Center Support Grant22025
P30CA047904Cancer Center Support Grant22025
P30DK020593Vanderbilt Diabetes Research Center22025
R01CA217987Metabolic barriers to T cell activation in clear cell renal cell carcinoma22025
R01DK105550Exploiting metabolic vulnerabilities of CD4 T cell subsets to control inflammatory disease22025

Source NIH's project files

See all 771 nih grants

Papers851

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
The DDIT4L-TOM40-ATP5A pathway suppresses glioblastoma oncogenesis.Genes Dis202742733534PubTator, text miningPubMed
Stephania cepharantha Hayata (Baiyaozi) attenuates cirrhosis-associated intestinal barrier injury by restoring mitochondrial function and suppressing PI3K/AKT signaling.J Ethnopharmacol202742586397PubTator, text miningPubMed
Epithelial QKI Protects Against Emphysema by Maintaining Mitochondrial Integrity.bioRxiv202642465480PubTator, text miningPubMed
Generative design and validation of therapeutic peptides for glioblastoma based on a potential target ATP5A.Brief Bioinform202642033056PubTator, text miningPubMed
Stem cells enhance mitochondrial function in experimental Huntington's disease.Stem Cells202641967079PubTator, text miningPubMed
Short-Chain Fatty Acids and Palmitate Induce Distinct Metabolic and Phenotypic Signatures in Normal and Ischemic Skeletal Muscle Microvascular Endothelial Cells.Cells202641892284PubTator, text miningPubMed
Glycolytic reprogramming mediated by the ADAM12/IGF1 axis promotes ossification of the posterior longitudinal ligament.Cell Death Discov202641881952PubTator, text miningPubMed
Ambrisentan attenuates cisplatin-related mitochondrial dysfunction in the heart via regulation of p53 and NF-κB signaling.Sci Rep202641876703PubTator, text miningPubMed
Global molecular landscape of early MASLD progression in human obesity.Elife202641870035PubTator, text miningPubMed
COG5 deficiency disrupts cellular copper homeostasis and underlies the impaired mitochondrial OXPHOS function.PLoS Genet202641824529PubTator, text miningPubMed

See all 851 papers

None in this release

  • Drugs
  • Trials

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/522

GET https://conductscience.org/api/genes/v1/522/patents?page=2